Clinical Trial

tESCS for Upper Limb Rehab in Spinal Cord Injury

Study acronym: SCIRUS
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Regaining hand and arm function is an important step towards regaining independence following high-level spinal cord injury (tetraplegia). The delivery of small electrical pulses over the skin above the spinal cord, called transcutaneous spinal cord stimulation (tESCS), appears to improve the arm and hand function of people who have had tetraplegia for several years when delivered at the same time as upper limb therapy. However, tESCS has not been tested in people who have a new spinal cord injury. It should be straightforward to deliver tESCS during standard upper limb therapy sessions to inpatients receiving primary rehabilitation. The investigators want to test the practical aspects of delivering this intervention and also to compare recovery between a group of people who only receive upper limb therapy and a group who receive upper limb therapy and tESCS. If successful, tESCS could in the future be used as part of regular therapy following an acute spinal cord injury. Benefits could include faster and better recovery, reduced stay in hospital, and reduced NHS costs.
Trial Details
NCT Number NCT07208188
Lead Sponsor NHS Greater Glasgow and Clyde
Collaborators: University of Glasgow, The Queen Elizabeth Hospital
Conditions Spinal Cord Injuries (SCI)
Enrollment 20 participants
Start Date 2025-11
Primary Completion 2027-10 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-06